Efficient Tumor Eradication at Ultralow Drug Concentration via Externally Controlled and Boosted Metallic Iron Magnetoplasmonic Nanocapsules.
breast cancer
magnetic manipulation
nanocapsules
paclitaxel
photothermal therapy
Journal
ACS nano
ISSN: 1936-086X
Titre abrégé: ACS Nano
Pays: United States
ID NLM: 101313589
Informations de publication
Date de publication:
14 02 2023
14 02 2023
Historique:
pubmed:
6
12
2022
medline:
17
2
2023
entrez:
5
12
2022
Statut:
ppublish
Résumé
With the aim to locally enhance the efficacy of cancer nanotherapies, here we present metal iron based magnetoplasmonic drug-loaded nanocapsules (MAPSULES), merging powerful external magnetic concentration in the tumor and efficient photothermal actuation to locally boost the drug therapeutic action at ultralow drug concentrations. The MAPSULES are composed of paclitaxel-loaded polylactic-
Identifiants
pubmed: 36468629
doi: 10.1021/acsnano.2c05733
pmc: PMC9933591
doi:
Substances chimiques
Nanocapsules
0
Iron
E1UOL152H7
Paclitaxel
P88XT4IS4D
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1946-1958Références
ACS Nano. 2019 Jul 23;13(7):7716-7728
pubmed: 31173684
J Nanobiotechnology. 2018 Sep 19;16(1):71
pubmed: 30231877
Nat Mater. 2013 Nov;12(11):991-1003
pubmed: 24150417
Chem Rev. 2008 Jun;108(6):2064-110
pubmed: 18543879
Chem Soc Rev. 2012 Mar 7;41(5):1911-28
pubmed: 22037623
ACS Appl Mater Interfaces. 2016 Nov 30;8(47):32159-32169
pubmed: 27808492
ACS Appl Mater Interfaces. 2020 Feb 5;12(5):5476-5487
pubmed: 31910619
Small. 2009 Aug 17;5(16):1862-8
pubmed: 19384879
J Nanosci Nanotechnol. 2010 Sep;10(9):5527-39
pubmed: 21133071
Sci Rep. 2018 Feb 1;8(1):2082
pubmed: 29391477
Sci Rep. 2021 May 13;11(1):10278
pubmed: 33986437
Drug Des Devel Ther. 2017 Mar 06;11:659-668
pubmed: 28293102
Nat Rev Drug Discov. 2021 Feb;20(2):101-124
pubmed: 33277608
J Control Release. 2019 Oct;311-312:26-42
pubmed: 31401198
ACS Appl Mater Interfaces. 2020 Dec 23;12(51):56767-56781
pubmed: 33289550
J Control Release. 2009 Jan 5;133(1):11-7
pubmed: 18950666
Adv Healthc Mater. 2020 May;9(9):e1901058
pubmed: 32196144
PLoS One. 2018 Nov 8;13(11):e0206109
pubmed: 30408068
Pharm Res. 1993 Jul;10(7):1093-5
pubmed: 8378254
Materials (Basel). 2022 Mar 14;15(6):
pubmed: 35329574
Nanoscale. 2014 Aug 7;6(15):9230-40
pubmed: 24980122
Small. 2018 Jun;14(24):e1800868
pubmed: 29761629
Drug Deliv. 2014 Dec;21(8):627-35
pubmed: 24344769
Theranostics. 2020 Jun 25;10(17):7921-7924
pubmed: 32685029
Adv Sci (Weinh). 2021 Dec;8(23):e2103334
pubmed: 34664422
J Control Release. 2017 Oct 28;264:219-227
pubmed: 28867377
Nanoscale. 2014 Mar 21;6(6):3274-82
pubmed: 24509646
J Control Release. 2020 May 10;321:589-601
pubmed: 32114091
Opt Express. 2020 Mar 16;28(6):9002-9013
pubmed: 32225514
Nanomaterials (Basel). 2019 Jan 13;9(1):
pubmed: 30642128
BMC Cancer. 2008 Jul 25;8:212
pubmed: 18657273
J Phys Chem C Nanomater Interfaces. 2007 Sep;111(9):3636-3641
pubmed: 19011696
Nano Res. 2019 Feb;12:273-279
pubmed: 31832124
Pharm Res. 2005 Dec;22(12):2079-90
pubmed: 16132339
Chem Rev. 2012 Nov 14;112(11):5818-78
pubmed: 23043508
Nano Today. 2012 Dec 1;7(6):606-618
pubmed: 23243460
ACS Appl Mater Interfaces. 2020 Jul 15;12(28):31292-31308
pubmed: 32551473
Nanotechnology. 2019 Mar 15;30(11):112001
pubmed: 30609414
ACS Nano. 2019 May 28;13(5):5785-5798
pubmed: 30990673
Front Bioeng Biotechnol. 2019 Oct 22;7:293
pubmed: 31696114
ACS Appl Mater Interfaces. 2021 Oct 13;13(40):47871-47881
pubmed: 34597022